OC-0055: Telomere shortening in lymphocytes of Hodgkin lymphoma with coronary artery disease post treatment
Radhia M’kacher(Genopole (France)), Laure Sabatier(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Leonhard Heidingsfelder(Robert Bosch (Germany)), Bruno Colicchio(Université de Haute-Alsace), Jean‐François Paul(Institute Mutualiste Montsouris), Michelle Ricoul(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Jean Bourhis(University of Lausanne), T. Girinsky, Patrice Carde(Institut Gustave Roussy), Serge Koscielny(Institut Gustave Roussy)
Cited by 0
Related Papers
Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
|Head & Neck|2005|1.8k
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
|Journal of Clinical Oncology|2010|806
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
|The Lancet Oncology|2021|618